Exhibit Hall Presentation Theater: Breakthrough Innovation: The First and Only Bispecific T-cell Engager (BiTE®) Therapy for 2L+ Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Amgen
Friday, November 15, 2024
3:15 PM – 3:45 PM CT
Location: Longhorn Hall E, Theater 3
Andrew Guinigundo, MSN, RN, CNP, ANP-BC, FAPO Cincinnati Cancer Advisors
